Home > Products > API > Mitomycin C
Mitomycin C
  • Mitomycin CMitomycin C

Mitomycin C

Product Name: Mitomycin C
Formulae hypotheticae: C15H18N4O5
M. Pondus: 334.33
CAS Subcriptio Number: 50-07-7 "

Model:CAS NO:50-07-7

Mitte Inquisitionem

depictio producti

Mitomycin C

Product nomen:Mitomycin C 50-07-7
CAS No:50-07-7
Specification: in domo

Nomen Mitomycin C
Synonyma MitomycinC(Ametycine);Azirino[2',3':3,4]pyrrolo[1,2-a]indolum-4,7-dione,6-amino-8-[[(aminocarbonyl)oxy]methyl]-1 ,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methyl -;MytomycinC;[1aR-(1a,8β,8a,8bα)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a- methoxy-5-methylazirino[2',3':3,4]pyrrolo[1,2Chemic albook-α] indole-4,7-dione;6-Amino-1,1a,2,8,8a,8b-hexahydro-8-(hydroxymethyl)-8a-methox-5-methylazirino[2',3'; 1,2-;MitonyycinC[1aS-(1a,8β,8aα ,8bα)]-6-Amino-8-[[(aminocarbonyl)oxy]methyl]-1,1a,2,8,8a,8b-hexahydro-8a-methoxy-5-methylazirino[2',3':3 ,4] pyrrolo[1,2-a]indole-4,7-dione;8balpha)]-8aalph.
copyRight
M CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C15H18N4O5
M. Pondus 334.33
CAS Subcriptio Number 50-07-7


Pertractatio et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Mitomycin C, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept